Effect of liraglutide on ambulatory blood pressure in patients with hypertension and type 2 diabetes: A randomized, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Effect of liraglutide on ambulatory blood pressure in patients with hypertension and type 2 diabetes: A randomized, double-blind, placebo-controlled trial

Published:2018-10-23 Issue:3 Volume:21 Page:517-524
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Liakos Aris¹^ORCID,Lambadiari Vaia²,Bargiota Alexandra³,Kitsios Konstantinos¹,Avramidis Iakovos⁴,Kotsa Kalliopi⁵,Gerou Spyridon⁶,Boura Panagiota¹,Tentolouris Nikolaos⁷,Dimitriadis George²,Tsapas Apostolos¹⁸^ORCID

Affiliation:

1. Second Medical Department; Aristotle University Thessaloniki; Thessaloniki Greece

2. Research Institute and Diabetes Center, Second Department of Internal Medicine; National and Kapodistrian University of Athens; Athens Greece

3. Department of Endocrinology and Metabolic Diseases; University of Thessaly; Larisa Greece

4. First Medical Department; G. Papanikolaou General Hospital; Thessaloniki Greece

5. Division of Endocrinology-Diabetes, First Department of Internal Medicine; Aristotle University Thessaloniki; Thessaloniki Greece

6. Analysi Iatriki S.A.; Thessaloniki Greece

7. First Department of Propedeutic and Internal Medicine; National and Kapodistrian University of Athens; Athens Greece

8. Harris Manchester College; University of Oxford; Oxford UK

Funder

Novo Nordisk

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.13541/fullpdf

Reference32 articles.

1. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications;Hypertension in Diabetes Study (HDS): I;J Hypertens,1993

2. Standards of medical care in diabetes-2018;American Diabetes Association;Diabetes Care,2018

3. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint National Committee (JNC 8);James;JAMA,2014

4. Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials;Vilsboll;BMJ,2012

5. Reductions in systolic blood pressure with liraglutide in patients with type 2 diabetes: insights from a patient-level pooled analysis of six randomized clinical trials;Fonseca;J Diabetes Complications,2014

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucagon‐like peptide‐1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta‐analysis and meta‐regression;Diabetes, Obesity and Metabolism;2024-03-20

2. The impact of GLP-1 receptor agonist liraglutide on blood pressure profile, hydration, natriuresis in diabetic patients with severely impaired kidney function;Scientific Reports;2024-02-29

3. Primordial Drivers of Diabetes Heart Disease: Comprehensive Insights into Insulin Resistance;Diabetes & Metabolism Journal;2024-01-31

4. Glucagon-like peptide-1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta-analysis and meta-regression;2024-01-30

5. Liraglutide does not increase heart rate of diabetic patients during acute myocardial infarction;Journal of Diabetes;2024-01-03